Drug database
Reporting
-
Adverse drug reaction (CS only)
-
Suspected defect in the quality of a medicine
-
Suspected presence of a counterfeit medicine
-
Use of an unauthorized medicinal product
-
Reporting of stocks of medicinal products
-
Launch, interruption, renewal or cessation of a medicine on the market
-
Reporting by marketing authorisation holders (according to Medicinal Products Act)
-
Non-interventional post-registration studies
-
Failed verification of protective elements
-
Status and movement of stocks of addictive substances listed in Annex 1 or 5 to the Government Regulation
-
Opening/termination of pharmacies, sales of reserved medicinal products and specialised departments of medical facilities
-
Reporting the originator’s price
-
Establishment, method of operation and change of address of a publicly accessible professional information service on medicinal products
-
Supplies of distributed medicines
-
Haemovigilance reporting
-
Batch release for selected medicines
-
Mail order dispensing of medicines
-
Change of contact details